1. Home
  2. CTNM vs ONEW Comparison

CTNM vs ONEW Comparison

Compare CTNM & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • ONEW
  • Stock Information
  • Founded
  • CTNM 2009
  • ONEW 2014
  • Country
  • CTNM United States
  • ONEW United States
  • Employees
  • CTNM N/A
  • ONEW N/A
  • Industry
  • CTNM
  • ONEW Auto & Home Supply Stores
  • Sector
  • CTNM
  • ONEW Consumer Discretionary
  • Exchange
  • CTNM Nasdaq
  • ONEW Nasdaq
  • Market Cap
  • CTNM 248.7M
  • ONEW 284.0M
  • IPO Year
  • CTNM 2024
  • ONEW 2020
  • Fundamental
  • Price
  • CTNM $12.16
  • ONEW $14.98
  • Analyst Decision
  • CTNM Strong Buy
  • ONEW Buy
  • Analyst Count
  • CTNM 5
  • ONEW 8
  • Target Price
  • CTNM $22.20
  • ONEW $19.43
  • AVG Volume (30 Days)
  • CTNM 194.4K
  • ONEW 97.7K
  • Earning Date
  • CTNM 11-05-2025
  • ONEW 11-13-2025
  • Dividend Yield
  • CTNM N/A
  • ONEW N/A
  • EPS Growth
  • CTNM N/A
  • ONEW N/A
  • EPS
  • CTNM N/A
  • ONEW N/A
  • Revenue
  • CTNM N/A
  • ONEW $1,790,054,000.00
  • Revenue This Year
  • CTNM N/A
  • ONEW $4.76
  • Revenue Next Year
  • CTNM N/A
  • ONEW $3.23
  • P/E Ratio
  • CTNM N/A
  • ONEW N/A
  • Revenue Growth
  • CTNM N/A
  • ONEW N/A
  • 52 Week Low
  • CTNM $3.35
  • ONEW $11.58
  • 52 Week High
  • CTNM $20.24
  • ONEW $26.78
  • Technical
  • Relative Strength Index (RSI)
  • CTNM 56.27
  • ONEW 40.36
  • Support Level
  • CTNM $10.65
  • ONEW $14.55
  • Resistance Level
  • CTNM $12.14
  • ONEW $16.50
  • Average True Range (ATR)
  • CTNM 0.92
  • ONEW 0.64
  • MACD
  • CTNM -0.21
  • ONEW -0.10
  • Stochastic Oscillator
  • CTNM 34.98
  • ONEW 26.39

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

Share on Social Networks: